Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05366010 · ClinicalTrials.gov registry record · NA
Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients
A NA study, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05366010 is a NA study that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 41 participants.
The verdict
NCT05366010, a NA study, was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The study will be a non-randomized open label pilot study comparing a retrospective control period to an active treatment period with oscillation and lung expansion (OLE) therapy.
Interventions
- DEVICE Oscillation and Lung Expansion (OLE) therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2024-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05366010
The ClinicalTrials.gov registry entry for NCT05366010 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oscillation and Lung Expansion (OLE) therapy is the first listed.
NCT05366010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05366010 about?
NCT05366010 is a clinical study titled "Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients". The study will be a non-randomized open label pilot study comparing a retrospective control period to an active treatment period with oscillation and lung expansion (OLE) therapy.
What is the current status of trial NCT05366010?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2021-11-04. Estimated completion is 2024-02-27.
What interventions are being tested in trial NCT05366010?
The interventions under investigation include: Oscillation and Lung Expansion (OLE) therapy (DEVICE).
Who is sponsoring clinical trial NCT05366010?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.